falsefalse

Genomic Testing for Improved Treatments in Breast Cancer - Episode 7

Real-World Evidence in Genomic Testing from SABCS 2023

,

Experts in breast cancer outline data presented at SABCS 2023, focusing on real-world evidence for genomic assays used in practice.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Evolving Treatment Paradigms for Early-Stage Breast Cancers
    EP. 2: Overview of Genomic Assays for Early-Stage Breast Cancer
    EP. 3: MammaPrint: A 70-Gene Signature Test for Patient with Breast Cancer
    EP. 4: Clinical Considerations of Genomic Testing in Early-Stage Breast Cancer
    EP. 5: FLEX Trial: Genomic Testing of HER2 Status in ER+/HER2-Breast Cancer
    EP. 6: Exploring Multigene Genomic Assays in High-Risk BC Patients
    Now Viewing
    EP. 7: Real-World Evidence in Genomic Testing from SABCS 2023
    EP. 8: Racial Disparities and Genomic Testing for Breast Cancer Patients
    EP. 9: Reflecting on Genomic Testing in Practice for Breast Cancer
    EP. 10: Ongoing Studies in Genomic Testing for Breast Cancer

    Related Content:

    Genomic Testing for Improved Treatments in Breast CancerInsightsBreast CancerInsights Video Series
    OncLive’s FDA Approval Report: The Regulatory Rundown for April 2025
    Dr Kuerer on Selective Surgery Omission After Response to Neoadjuvant Therapy in Invasive Breast Cancer
    Avutometinib/Abemaciclib/Fulvestrant Combo Is Active, Safe in CDK4/6 Inhibitor–Resistant HR+/HER2– Metastatic Breast Cancer
    x